About
I’m a Research Assistant at the Centre for the Business and Economics of Health at The University of Queensland.
My work focuses on health technology assessments and I’m a member of the UQ Evaluation Services Team (QUEST) – a research group that evaluates submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) in Australia. These evaluations help PBAC to inform their decision-making and provide evidence-based recommendations to the Minister for Health about which medicines should or should not be listed on the Pharmaceutical Benefits Scheme (PBS) and which vaccines should or should not be included in the National Immunisation Program (NIP).
In addition to health technology assessments, I have skills in research methods including systematic literature reviews and scoping reviews.
I recently completed my Master of Health Economics at UQ – my thesis focused on assessing the cost-effectiveness of introducing non-valent human papillomavirus (HPV) vaccines in India.
Research interests
Economic evaluations: use of evidence-based information, through cost-effectiveness analysis or cost-benefit analysis, to assist and improve the decision making of allocating health care resources.
Health technology assessments: use of scientific evidence to assess the quality, safety, efficacy, effectiveness and cost-effectiveness of health services.
Economic modelling techniques: methods to aid and inform healthcare decision-making.
Research impact
The work I’m doing to evaluate submissions for PBAC informs what pharmaceuticals and vaccines are made available to the Australian population, as decided by the Department of Health.
The findings of my master’s thesis may serve as useful evidence for policy-makers to make informed decisions regarding the introduction of HPV vaccines in India’s Universal Immunisation Programme (UIP).
Featured project
| Project title | Funding amount | Duration |
|---|---|---|
| Pharmaceutical Benefits Advisory Committee Assessment Unit Commonwealth Department of Health | Confidential | 2021 - 2025 |
Contact
If you are interested to work together, please email me.